Our Legacy.

MC3 was founded in 1991 by Dr. Robert Bartlett, and ScottMerz, PhD as a spin-off from the University of Michigan. Over the past three decades, MC3 has passionately advanced the innovation of intellectual property related to artificial heart and lung technologies and conducted important translation research to serve the ECMO community by solving complex clinical technology challenges.

Our Future.

Headquartered just outside of Ann Arbor in Dexter, Michigan,the company has entered an exciting new chapter as a healthcare device provider under the new ownership of Robert Foster, a visionary medical device manufacturing pioneer with a keen focus on cardiopulmonary devices solutions.The company is re-imagined as MC3 Cardiopulmonary with the goal to serve the global community by creating life restoring medical devices that address acute and chronic unmet cardiopulmonary clinical needs. ECMO is the most advanced form of life support, allowing gas exchange through blood carried outside of the body, instead of the airway. MC3 Cardiopulmonary is committed to developing innovative, safe, and effective ECMO products. Together with the ECMO community and our strategic global distribution partner Medtronic, we will transform healthcare by delivering ECLS broadly to patients suffering with acute respiratory and cardiac failure across a wide therapy spectrum.

Our Legacy. Our Vision.

MC3 was founded in 1991 by Dr. Robert Bartlett, “the father of ECMO”, and Scott Merz PhD, on a quest to discover new extracorporeal technologies and bridge new research to commercial endeavors.

In 2014, MC3 was purchased by Robert Foster, the founder of Avalon Laboratories. The company was reformed with the vision of developing and manufacturing life sustaining Extracorporeal Membrane Oxygenation (ECMO) products. MC3’s vision is to make standardized ECMO a reality and expand access to this lifesaving therapy. MC3 is committed to developing innovative, safe, and effective ECMO products. MC3 leverages years of successful medical technology development and brings together the world’s top talent to serve the ECLS community directly.

MC3’s vision is to make standardized ECMO a reality and expand access to this lifesaving therapy. MC3 is committed to developing innovative, safe, and effective ECMO products.

Dr. Robert Bartlett
Co-founder

Scott Merz
President and CEO, Co-founder

Robert Foster
Chairman of the Board

Our Vision

MC3’s vision is to make standardized ECMO a reality and expand access to this lifesaving therapy. MC3 is committed to developing innovative, safe, and effective ECMO products.

Our Partnership with Medtronic

In order to achieve our vision, MC3 has entered into a partnership with Medtronic that gives Medtronic exclusive distribution rights to our products. Like MC3, Medtronic sees the unmet need for better, widely available ECMO devices that can standardize care. Together, MC3 and Medtronic will provide robust devices, training and support to ECMO practitioners to maximize the number of patients who will benefit from ECMO.

Management Team

Scott Merz President & CEO, Co-founder

Scott Merz, PhD., Chief Executive Officer and Co-Founder, has 25+ years of experience in medical device research, development, and business formation. Scott holds 10+ patents and has led numerous licensing deals enabling the launch of several spinout device companies. He is a charter member of the Extracorporeal Life Support Organization (ELSO) and long-standing leader of the cardiopulmonary community.

Bill Sidor | Vice President Engineering

Bill Sidor, VP Engineering, has 30+ years of experience in medical device development, having introduced numerous surgical products during his tenure of management at DLP, Medtronic, and Avalon Laboratories.

Rio Foster | Vice President Sales & Marketing

Rio Foster, VP Sales and Marketing, has medical device expertise focused on launching innovative products and therapy strategies through a deep understanding of customer-focused insights, business strategy, and process. Prior to MC3, he worked at Maquet Cardiovascular and Avalon Laboratories.

Ted Chittenden | Vice President Operations & Manufacturing

Ted Chittenden, VP Operations, has vast experience with sterile disposables manufacturing and executive management, including previous leadership positions at Surge Cardiovascular, Cascade Engineering, and Medtronic.

Martha Rumford | Director of Regulatory Affairs and Quality

Martha Rumford,Director of Regulatory Affairs and Quality, has 25+ years experience in the areas of cardiopulmonary bypass disposables, heparin coatings, heart-lung machines, and active implantable heart assist devices. Martha’s experience includes regulatory submissions, risk management, quality planning, and technology transfer. She has held leadership positions at Becton Dickenson, Terumo, and 3M.

Catherine Schmidt | Chief Financial Officer

Catherine Schmidt, Chief Financial Officer, is an accomplished financial executive with 25+ years in public and private accounting. Catherine began her executive career at Arthur Anderson and has worked as the Chief Financial Officer for several companies within the healthcare, software, and automotive industries.

Board of Directors

Robert Foster | Chairman of the Board

Robert has 30+ years in the medical device industry. Robert founded Avalon Laboratories in 1990 and grew it into the world’s largest surgical cannula OEM manufacturer before selling it in 2008.  He acquired a majority share of MC3 in 2013 and provides visionary leadership to the executive team.

John Mack | Vice President & General Manager of Medtronic Cardiac Surgery

Medtronic's Cardiac Surgery business includes Cardiopulmonary, Blood Management, Cannula, MICS, OpCab, Ablation, Surgical Heart Valves and Repair. John has been with Medtronic for over 23 years and in the Structural Heat/Cardiac Surgery business since 2000. John has held a series of roles in Finance, Marketing, Business and Corporate Development. He is a past recipient of both the Wallin Leadership Award and the Medtronic Star of Excellence Award.

Scott Merz | President & CEO, Co-Founder

Scott has 25+ years of experience in medical device research, development, and business formation. Scott holds 10+ patents and has led numerous licensing deals enabling the launch of several spinout device companies. He is a charter member of the Extracorporeal Life Support Organization (ELSO) and long-standing leader of the cardiopulmonary community.

Bill Sidor | Vice President Engineering

Bill Sidor, VP Engineering, has 30+ years of experience in medical device development, having introduced numerous surgical products during his tenure of management at DLP, Medtronic, and Avalon Laboratories.

Rio Foster | Vice President Sales & Marketing

Rio Foster, VP Sales and Marketing, has medical device expertise focused on launching innovative products and therapy strategies through a deep understanding of customer-focused insights, business strategy, and process. Prior to MC3, he worked at Maquet Cardiovascular and Avalon Laboratories.

Christopher Ball | Managing Director, Critical Point Partners

Christopher is Managing Director of Critical Point Partners in Manhattan Beach, CA. Chris spent the first 15 years of his career developing safety-critical products for TRW and International Rectifier.

Advisers

Dr. Robert Bartlett | Co-founder and ECMO Adviser

Robert Bartlett, M.D., Board Member and Co-Founder, enjoyed a distinguished career at the University of Michigan and he continues his contributions to medicine as Professor Emeritus Surgery and as the Director of the Cardiopulmonary Physiology and Extracorporeal Circulation Research Laboratory. He is the founder of the Extracorporeal Life Support Organization (ELSO) and is a world-renowned expert and global lecturer in extracorporeal life support, intensive care, and surgery.

© 2018 MC3 Cardiopulmonary